melatonin has been researched along with Hyperactivity, Motor in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin is a potent antioxidant which showed anticonvulsant activities both in experimental and clinical studies." | 5.39 | Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy. ( Atanasova, D; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Moyanova, S; Pechlivanova, D; Petkova, Z; Stoynev, A; Tchekalarova, J, 2013) |
| "Melatonin is a potent antioxidant with neuroprotective activity in animal models of ischemic stroke, which based on its lack of serious toxicity has raised hopes that it might be used for human stroke treatment in the future." | 5.35 | Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. ( Abdallah, NB; Bacigaluppi, M; Bassetti, CL; Guo, Z; Hermann, DM; Kilic, E; Kilic, U; Reiter, RJ; Wolfer, DP, 2008) |
| "Melatonin is a potent antioxidant which showed anticonvulsant activities both in experimental and clinical studies." | 1.39 | Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy. ( Atanasova, D; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Moyanova, S; Pechlivanova, D; Petkova, Z; Stoynev, A; Tchekalarova, J, 2013) |
| "Melatonin is a potent antioxidant with neuroprotective activity in animal models of ischemic stroke, which based on its lack of serious toxicity has raised hopes that it might be used for human stroke treatment in the future." | 1.35 | Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. ( Abdallah, NB; Bacigaluppi, M; Bassetti, CL; Guo, Z; Hermann, DM; Kilic, E; Kilic, U; Reiter, RJ; Wolfer, DP, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tchekalarova, J | 1 |
| Petkova, Z | 1 |
| Pechlivanova, D | 1 |
| Moyanova, S | 1 |
| Kortenska, L | 1 |
| Mitreva, R | 1 |
| Lozanov, V | 1 |
| Atanasova, D | 1 |
| Lazarov, N | 1 |
| Stoynev, A | 1 |
| Norman, TR | 1 |
| Cranston, I | 1 |
| Irons, JA | 1 |
| Gabriel, C | 1 |
| Dekeyne, A | 1 |
| Millan, MJ | 1 |
| Mocaër, E | 1 |
| Kilic, E | 1 |
| Kilic, U | 1 |
| Bacigaluppi, M | 1 |
| Guo, Z | 1 |
| Abdallah, NB | 1 |
| Wolfer, DP | 1 |
| Reiter, RJ | 2 |
| Hermann, DM | 1 |
| Bassetti, CL | 1 |
| De Leersnyder, H | 1 |
| de Blois, MC | 1 |
| Vekemans, M | 1 |
| Sidi, D | 1 |
| Villain, E | 1 |
| Kindermans, C | 1 |
| Munnich, A | 1 |
| Sackman, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy: A Randomized, add-on Placebo-controlled Clinical Trial[NCT03590197] | Phase 4 | 104 participants (Actual) | Interventional | 2018-08-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for melatonin and Hyperactivity, Motor
| Article | Year |
|---|---|
Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy.
Topics: Analysis of Variance; Animals; Central Nervous System Depressants; Chromatography, High Pressure Liq | 2013 |
Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
Topics: Acetamides; Animals; Antidepressive Agents; Behavior, Animal; Hyperkinesis; Indoles; Male; Melatonin | 2012 |
Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice.
Topics: Animals; Antioxidants; Anxiety; Brain Ischemia; Cell Survival; Doublecortin Domain Proteins; Hyperki | 2008 |
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Behavior; Child; Child, Preschool; Chromosomes, | 2001 |
Hyperactivity in the blind-anosmic female rat: role of the pineal gland.
Topics: Animals; Blindness; Female; Humans; Hyperkinesis; Melatonin; Motor Activity; Olfaction Disorders; Pi | 1977 |